Equity

Quarterly ResultsHome > Equity > Corporate Information > Quarterly Results

Glaxosmithkline Pharmaceuticals LtdIndustry : Pharmaceuticals - Multinational
BSE Code:500660 NSE Symbol: GLAXO P/E (TTM) :56.84
ISIN Demat:INE159A01016 Div & Yield %:1.5 EPS (TTM) :37.52
Book Value (RS) :91.3566062 Market Cap (Rs Cr.):36130.07 Face Value (RS) :10
    Change Company 
Quarters :  
ParticularsDec 2023Sep 2023Jun 2023Mar 2023
 (Rs in Cr)(Rs in Cr)(Rs in Cr)(Rs in Cr)
Gross Sales 804.98953.38738.02782.16
Other Operating Income 0.000.000.000.00
Other Income  28.3428.4754.1038.37
Total Income 833.32981.85792.12820.53
Total Expenditure  750.78666.80596.77615.40
PBIDT 82.54315.05195.35205.13
Interest  0.320.430.280.65
PBDT 82.22314.62195.07204.48
Depreciation 17.1118.1116.3617.18
Tax 31.3290.6052.6356.58
Fringe Benefit Tax 0.000.000.000.00
Deferred Tax -11.70-9.63-4.50-0.76
Reported Profit After Tax 45.49215.54130.58131.48
Extra-ordinary Items  -131.990.0012.217.26
Adjusted Profit After Extra-ordinary item 177.48215.54118.37124.22
     
EPS (Unit Curr.) 2.6912.726.947.28
EPS (Adj) (Unit Curr.) 2.6912.726.947.28
Calculated EPS (Unit Curr.) 2.6912.727.717.76
Calculated EPS (Adj) (Unit Curr.) 2.6912.727.717.76
Calculated EPS (Ann.) (Unit Curr.) 10.7450.8930.8331.04
Calculated EPS (Adj) (Ann.) (Unit Curr.) 10.7450.8930.8331.04
Book Value (Unit Curr.) 0.000.000.000.00
Dividend (%) 0.00320.000.000.00
Equity 169.41169.41169.41169.41
Reserve & Surplus 0.000.000.000.00
Face Value 10.0010.0010.0010.00
     
Public Shareholding (No. Of Shares) 0.000.000.000.00
Public Shareholding (% in Equity) 0.000.000.000.00
     
Pledged/Encumbered - No. of Shares 0.000.000.000.00
Pledged/Encumbered - % in Total Promoters Holding 0.000.000.000.00
Pledged/Encumbered - % in Total Equity 0.000.000.000.00
     
Non Encumbered - No. of Shares 0.000.000.000.00
Non Encumbered - % in Total Promoters Holding 0.000.000.000.00
Non Encumbered - % in Total Equity 0.000.000.000.00
     
PBIDTM(%) 10.2533.0526.4726.23
PBDTM(%) 10.2133.0026.4326.14
PATM(%) 5.6522.6117.6916.81

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)